vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $51.6M, roughly 1.7× Velocity Financial, Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs 7.4%, a 59.9% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 32.8%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 32.3%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

HROW vs VEL — Head-to-Head

Bigger by revenue
HROW
HROW
1.7× larger
HROW
$89.1M
$51.6M
VEL
Growing faster (revenue YoY)
HROW
HROW
+0.5% gap
HROW
33.3%
32.8%
VEL
Higher net margin
VEL
VEL
59.9% more per $
VEL
67.3%
7.4%
HROW
More free cash flow
VEL
VEL
$9.8M more FCF
VEL
$17.9M
$8.1M
HROW
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
32.3%
VEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
VEL
VEL
Revenue
$89.1M
$51.6M
Net Profit
$6.6M
$34.8M
Gross Margin
79.3%
Operating Margin
17.5%
97.0%
Net Margin
7.4%
67.3%
Revenue YoY
33.3%
32.8%
Net Profit YoY
-2.2%
67.0%
EPS (diluted)
$0.20
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
VEL
VEL
Q4 25
$89.1M
$51.6M
Q3 25
$71.6M
$49.1M
Q2 25
$63.7M
$47.6M
Q1 25
$47.8M
$37.5M
Q4 24
$66.8M
$38.9M
Q3 24
$49.3M
$35.1M
Q2 24
$48.9M
$32.4M
Q1 24
$34.6M
$29.5M
Net Profit
HROW
HROW
VEL
VEL
Q4 25
$6.6M
$34.8M
Q3 25
$1.0M
$25.4M
Q2 25
$5.0M
$26.0M
Q1 25
$-17.8M
$18.9M
Q4 24
$6.8M
$20.8M
Q3 24
$-4.2M
$15.8M
Q2 24
$-6.5M
$14.8M
Q1 24
$-13.6M
$17.3M
Gross Margin
HROW
HROW
VEL
VEL
Q4 25
79.3%
Q3 25
75.3%
Q2 25
74.5%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
VEL
VEL
Q4 25
17.5%
97.0%
Q3 25
20.6%
72.1%
Q2 25
17.9%
71.3%
Q1 25
-23.5%
71.7%
Q4 24
19.3%
82.5%
Q3 24
2.7%
60.6%
Q2 24
3.1%
61.3%
Q1 24
-20.0%
78.8%
Net Margin
HROW
HROW
VEL
VEL
Q4 25
7.4%
67.3%
Q3 25
1.4%
51.7%
Q2 25
7.8%
54.6%
Q1 25
-37.2%
50.4%
Q4 24
10.1%
53.5%
Q3 24
-8.6%
45.1%
Q2 24
-13.2%
45.6%
Q1 24
-39.2%
58.5%
EPS (diluted)
HROW
HROW
VEL
VEL
Q4 25
$0.20
$0.90
Q3 25
$0.03
$0.65
Q2 25
$0.13
$0.69
Q1 25
$-0.50
$0.51
Q4 24
$0.19
$0.56
Q3 24
$-0.12
$0.44
Q2 24
$-0.18
$0.42
Q1 24
$-0.38
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$72.9M
$92.1M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$672.5M
Total Assets
$399.5M
$7.4B
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
VEL
VEL
Q4 25
$72.9M
$92.1M
Q3 25
$74.3M
$99.0M
Q2 25
$53.0M
$79.6M
Q1 25
$66.7M
$51.7M
Q4 24
$47.2M
$49.9M
Q3 24
$72.6M
$44.1M
Q2 24
$71.0M
$47.4M
Q1 24
$76.0M
$34.8M
Total Debt
HROW
HROW
VEL
VEL
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
VEL
VEL
Q4 25
$52.4M
$672.5M
Q3 25
$47.0M
$634.3M
Q2 25
$49.7M
$597.9M
Q1 25
$56.5M
$563.2M
Q4 24
$69.7M
$516.9M
Q3 24
$58.0M
$484.6M
Q2 24
$58.5M
$471.3M
Q1 24
$60.6M
$452.9M
Total Assets
HROW
HROW
VEL
VEL
Q4 25
$399.5M
$7.4B
Q3 25
$363.1M
$7.0B
Q2 25
$345.0M
$6.5B
Q1 25
$364.2M
$6.0B
Q4 24
$389.0M
$5.5B
Q3 24
$351.5M
$5.2B
Q2 24
$306.6M
$4.9B
Q1 24
$295.5M
$4.6B
Debt / Equity
HROW
HROW
VEL
VEL
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
VEL
VEL
Operating Cash FlowLast quarter
$8.4M
$18.2M
Free Cash FlowOCF − Capex
$8.1M
$17.9M
FCF MarginFCF / Revenue
9.1%
34.6%
Capex IntensityCapex / Revenue
0.4%
0.5%
Cash ConversionOCF / Net Profit
1.27×
0.52×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
VEL
VEL
Q4 25
$8.4M
$18.2M
Q3 25
$16.6M
$11.5M
Q2 25
$-803.0K
$7.7M
Q1 25
$19.7M
$3.5M
Q4 24
$-17.8M
$37.8M
Q3 24
$3.0M
$-17.6M
Q2 24
$-2.7M
$11.5M
Q1 24
$-4.6M
$10.6M
Free Cash Flow
HROW
HROW
VEL
VEL
Q4 25
$8.1M
$17.9M
Q3 25
$16.4M
$11.4M
Q2 25
$-969.0K
$7.6M
Q1 25
$19.5M
$3.5M
Q4 24
$-18.3M
$37.5M
Q3 24
$2.3M
$-17.6M
Q2 24
$-3.1M
$11.4M
Q1 24
$-4.7M
$10.5M
FCF Margin
HROW
HROW
VEL
VEL
Q4 25
9.1%
34.6%
Q3 25
22.9%
23.2%
Q2 25
-1.5%
15.9%
Q1 25
40.8%
9.2%
Q4 24
-27.4%
96.4%
Q3 24
4.8%
-50.3%
Q2 24
-6.3%
35.1%
Q1 24
-13.6%
35.8%
Capex Intensity
HROW
HROW
VEL
VEL
Q4 25
0.4%
0.5%
Q3 25
0.3%
0.1%
Q2 25
0.3%
0.2%
Q1 25
0.4%
0.2%
Q4 24
0.8%
0.7%
Q3 24
1.2%
0.2%
Q2 24
0.7%
0.3%
Q1 24
0.3%
0.1%
Cash Conversion
HROW
HROW
VEL
VEL
Q4 25
1.27×
0.52×
Q3 25
16.26×
0.45×
Q2 25
-0.16×
0.29×
Q1 25
0.19×
Q4 24
-2.62×
1.81×
Q3 24
-1.11×
Q2 24
0.78×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons